United States · Venture startup
5 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$3.7Mraised across 5 rounds since 2012, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $1.2M sold, first sale Nov 2015
From a historical funding record
From a historical funding record
No investor was named in the report.
From a historical funding recordSEC filing: $300K sold, first sale Dec 2013
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Cultivation Capital
BioGenerator
St. Louis Arch Angels
Missouri Technology Corporation
Helix Fund
ABC LaboratoriesMissing a round, or an investor who was in one? Tell us.
Euclises Pharmaceuticals's investors include Cultivation Capital, BioGenerator, St. Louis Arch Angels, Missouri Technology Corporation and Helix Fund, and 1 more on record.
Euclises Pharmaceuticals has raised $3.7M across 5 rounds since 2012.
Euclises Pharmaceuticals's most recent round was a Venture of $1.2M in Dec 2016.
Euclises Pharmaceuticals's largest round on record is $1.3M (Series A), in Sept 2014.
Euclises Pharmaceuticals's first round on record, in May 2012, was backed by St. Louis Arch Angels.
Euclises Pharmaceuticals's latest named round is a Venture, in Dec 2016.
Euclises Pharmaceuticals is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
